XPAR
LBIRD
Market cap557mUSD
Oct 09, Last price
22.50EUR
1D
2.74%
1Q
-17.73%
Jan 2017
598.01%
Name
Lumibird SA
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
A global leader, Lumibird S.A. specializes in the development, manufacturing, and distribution of a wide array of laser technologies. Its sophisticated laser products are deployed worldwide across scientific, industrial, and medical sectors. The company's operations are divided into two key segments: Photonics and Medical. Within its Photonics division, Lumibird offers an extensive portfolio, including solid-state lasers, high-power laser diodes, fiber lasers, and related amplifiers and components. This segment also provides advanced photonics solutions for time-of-flight LiDAR, range-finding, and Doppler LiDAR systems for wind measurement. These offerings are critical for industrial and scientific advancements, defense and space operations, and diverse LiDAR sensing needs. Concurrently, the Medical division delivers comprehensive medical and ophthalmological solutions, encompassing everything from diagnosis to laser-based therapies. Established in 1970, Lumibird S.A. maintains its corporate headquarters in Lannion, France.
Key people
Marc Le Flohic
Chairman of the Board, Chief Executive Officer · since 2016
Nicolas Ballif
Chief Human Resources Officer
Sonia Rutnam
Group General Secretary, General Director of Finance, Information Systems and Human Resources · since 2021
Alexandre Billard
Purchasing Director
Jean-Francois Coutris
Director - Representative of ESIRA · since 2016
Ajit Jayaratnam
Director (Non Voting Member) · since 2024
Gwenaelle Le Flohic
Director · since 2020
Emmanuel Cueff
Independent Director · since 2017
Marie Begona Lebrun
Independent Director · since 2016
Marie-Helene Sergent
Independent Director · since 2022
Headquarters & legal address
2 RUE PAUL SABATIER
LANNION 22300
FR
LANNION 22300
FR
Valuation
Title EUR in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||